01 / Contract Profile
75A50122C00068 Federal Contract Award
Agency code 7505
BIOLINK - TO INVESTIGATE AND DETERMINE IF TREATMENT WITH RAMATROBAN, ADMINISTERED FOR 28 DAYS TO HOSPITALIZED, NON-ICU PATIENTS WITH COVID-19 PNEUMONIA, REDUCES THE RISK OF SUBSEQUENT DEVELOPMENT OF PASC OVER THE ENSUING 11 MONTHS. PROVIDED DATA
02 / Contract Size and Status
What is the recorded size and timing of this contract?
03 / Spending Trend
75A50122C00068 contract spending by fiscal year
Annual net obligations across the complete period available for this agency and PIID, from the first recorded fiscal year through the latest contract action.
Latest fiscal year obligations-$242.8K
FY 2025Net obligationsComplete recorded range
| Fiscal year | Net obligations | Actions | Change |
|---|---|---|---|
| FY 2022 | $750.0K | 1 | — |
| FY 2023 | $0 | 2 | −100.0% |
| FY 2024 | -$300.0K | 1 | — |
| FY 2025 | -$242.8K | 1 | +19.1% |
04 / Federal Buyer
Which organization manages this contract?
| Department | Contracting agency | Contracting office |
|---|---|---|
| HEALTH AND HUMAN SERVICES, DEPARTMENT OF | OFFICE OF ASSISTANT SECRETARY FOR PREPAREDNESS AND RESPONSE | BARDA - ASPR / DAAPPO / BARDA DCMA |
05 / Contractor
Who holds this federal contract?
BIOLINK LIFE SCIENCES INC
UEI GUSQRGKRZ4C9 · CAGE 1WR74
06 / NAICS Industries
Which industries classify this contract?
| Code | Description | Obligations | Actions | Share |
|---|---|---|---|---|
| 541715 | RESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT NANOTECHNOLOGY AND BIOTECHNOLOGY) | $207.2K | 5 | 100.0% |
07 / Products and Services
What products or services were purchased?
| Code | Description | Obligations | Actions | Share |
|---|---|---|---|---|
| AN15 | HEALTH R&D SERVICES; HEALTH CARE SERVICES; EXPENSES FOR R&D FACILITIES AND MAJOR EQUIPMENT | $207.2K | 5 | 100.0% |
08 / Place of Performance
Where is the work recorded?
CARY, WAKE, NORTH CAROLINA, UNITED STATES
ZIP 275135813
09 / Contract Actions
What modifications and obligations were recorded?
| Signed date | Modification | Obligation | Contracting office | NAICS | PSC |
|---|---|---|---|---|---|
| Jul 16, 2025 | P00004 | -$242.8K | BARDA - ASPR / DAAPPO / BARDA DCMAOffice code 75A501 | 541715 | AN15 |
| May 14, 2024 | P00003 | -$300.0K | BARDA - ASPR / DAAPPO / BARDA DCMAOffice code 75A501 | 541715 | AN15 |
| Nov 2, 2023 | P00002 | $0 | BARDA - ASPR / DAAPPO / BARDA DCMAOffice code 75A501 | 541715 | AN15 |
| Feb 16, 2023 | P00001 | $0 | BARDA - ASPR / DAAPPO / BARDA DCMAOffice code 75A501 | 541715 | AN15 |
| Sep 21, 2022 | Base action | $750.0K | BARDA - ASPR / DAAPPO / BARDA DCMAOffice code 75A501 | 541715 | AN15 |
10 / Reading the Contract
How should this award record be interpreted?
Read the PIID as a transaction history, not as a single purchase price. Net obligations combine the base action with later increases, reductions, corrections, and deobligations recorded under the same contract.
Verify the buyer
Agency and office identify who manages the procurement relationship.
Follow modifications
Each action can change funding, scope, dates, or administrative terms.
Compare the market
Use NAICS, PSC, and the contractor profile to identify related buyers and competitors.